Literature DB >> 31959477

Vitamin D: A magic bullet or a myth?

P L M Reijven1, P B Soeters2.   

Abstract

The interest in Vitamin D (Vit D) is increased after the finding of Vit D receptors in many different cells. This led to the hypothesis that Vit D may have more impact on human health than its role in bone health. Epidemiological studies found associations between low plasma levels of Vit D and the prevalence of many diseases. However, Large RCTs did not find convincing evidence for a positive effect of Vit D supplementation on cancer, cardiovascular disease, auto-immune disease and inflammatory diseases. In this review, the results are described of a literature search regarding the relationship between Vit D status and different diseases. Pubmed was used to find systematic reviews of observational studies describing the association between Vit D status, diseases (cancer, coronary heart diseases, auto-immune diseases, sepsis) and mortality. Subsequently, a search was performed for RCTs and the results of large RCTs are described. Studies with a positive intervention effect on primary or secondary outcome variables are summarized. No exclusion criteria were used. The metabolism of Vit D is reviewed, its endogenous production and the intake from food, its activation and transport in the body. The article addresses the effects of diseases on the metabolism of Vit D with special focus on the role of Vit D Binding Protein and its effects on assessing Vit D status. Studies addressing the association between vitamin D status and cancer, cardiovascular diseases, auto-immune diseases, inflammation and severe illness are reviewed. A search for RCTs with positive effects of Vit D supplementation on different diseases yielded only a few studies. The vast majority of RCTs showed no significant positive effects. The presumed high prevalence of Vit D deficiency is questioned based on these results and on altered concentrations of Vit D binding protein, leading to low Vit D levels in plasma but not to low active Vit D levels during disease related inflammation In these conditions, plasma levels of Vit D are therefore not a valid reflection of Vit D status. Reversed causality is described as a possible factor interfering with the correct assessment of the Vit D status. It is concluded that further widespread fortification of foods and stimulation of supplement use should be reconsidered.
Copyright © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Deficiency; Metabolism; Supplementation; Vitamin D; Vitamin D binding protein

Mesh:

Substances:

Year:  2020        PMID: 31959477     DOI: 10.1016/j.clnu.2019.12.028

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  12 in total

1.  Vitamin D 25OH Deficiency and Mortality in Moderate to Severe COVID-19: A Multi-Center Prospective Observational Study.

Authors:  Laura Bogliolo; Emanuele Cereda; Catherine Klersy; Ludovico De Stefano; Federica Lobascio; Sara Masi; Silvia Crotti; Serena Bugatti; Carlomaurizio Montecucco; Stefania Demontis; Annalisa Mascheroni; Nadia Cerutti; Alberto Malesci; Salvatore Corrao; Riccardo Caccialanza
Journal:  Front Nutr       Date:  2022-07-05

Review 2.  The Multiple Effects of Vitamin D against Chronic Diseases: From Reduction of Lipid Peroxidation to Updated Evidence from Clinical Studies.

Authors:  Massimiliano Berretta; Vincenzo Quagliariello; Alessia Bignucolo; Sergio Facchini; Nicola Maurea; Raffaele Di Francia; Francesco Fiorica; Saman Sharifi; Silvia Bressan; Sara N Richter; Valentina Camozzi; Luca Rinaldi; Carla Scaroni; Monica Montopoli
Journal:  Antioxidants (Basel)       Date:  2022-05-30

Review 3.  The Progress of the Prevention and Treatment of Vitamin D to Tuberculosis.

Authors:  Li Cai; Gaoming Wang; Peijun Zhang; Xinyi Hu; Hao Zhang; Fan Wang; Yeqing Tong
Journal:  Front Nutr       Date:  2022-05-17

4.  Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19.

Authors:  G Mazziotti; E Lavezzi; A Brunetti; M Mirani; G Favacchio; A Pizzocaro; M T Sandri; A Di Pasquale; A Voza; M Ciccarelli; A G Lania
Journal:  J Endocrinol Invest       Date:  2021-03-05       Impact factor: 5.467

5.  Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy, Italy.

Authors:  Emanuele Cereda; Laura Bogliolo; Federica Lobascio; Michela Barichella; Anna Lena Zecchinelli; Gianni Pezzoli; Riccardo Caccialanza
Journal:  Nutrition       Date:  2020-11-11       Impact factor: 4.008

6.  The Interaction of Vitamin D and Corticosteroids: A Mortality Analysis of 26,508 Veterans Who Tested Positive for SARS-CoV-2.

Authors:  Jimmy T Efird; Ethan J Anderson; Charulata Jindal; Thomas S Redding; Andrew D Thompson; Ashlyn M Press; Julie Upchurch; Christina D Williams; Yuk Ming Choi; Ayako Suzuki
Journal:  Int J Environ Res Public Health       Date:  2021-12-31       Impact factor: 3.390

7.  Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19?

Authors:  Federica Saponaro; Maria Franzini; Chukwuma Okoye; Rachele Antognoli; Beatrice Campi; Marco Scalese; Tommaso Neri; Laura Carrozzi; Fabio Monzani; Riccardo Zucchi; Alessandro Celi; Aldo Paolicchi; Alessandro Saba
Journal:  Front Immunol       Date:  2022-01-24       Impact factor: 7.561

8.  Influence of 25-hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis.

Authors:  Andrea Crafa; Rossella Cannarella; Rosita A Condorelli; Laura M Mongioì; Federica Barbagallo; Antonio Aversa; Sandro La Vignera; Aldo E Calogero
Journal:  EClinicalMedicine       Date:  2021-06-18

9.  COVID-19 mortality is associated with low vitamin D levels in patients with risk factors and/or advanced age.

Authors:  Tímea Jenei; Sándor Jenei; László T Tamás; Ákos Putics; Márta Knausz; Irén Hegedüs; Imre Dinnyés; Zsuzsanna Szalai; Tamás F Molnár; Béla Büki
Journal:  Clin Nutr ESPEN       Date:  2021-11-24

10.  Bile Acid Malabsorption as a Consequence of Cancer Treatment: Prevalence and Management in the National Leading Centre.

Authors:  Caroline Gee; Catherine Fleuret; Ana Wilson; Daniel Levine; Ramy Elhusseiny; Ann Muls; David Cunningham; Darina Kohoutova
Journal:  Cancers (Basel)       Date:  2021-12-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.